Browsing by Yonsei Author : Cho, Byoung Chul

eperson profile image
Name:
Cho, Byoung Chul [조병철]
orcid http://orcid.org/0000-0002-5562-270X
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (7401747804)

Keyword Cloud

Researcher Network

Showing results 151 to 200 of 230

This table browses all dspace content
Issue DateTitleJournal Title
2015Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma. ONCOTARGET
2015Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neckCLINICAL CANCER RESEARCH
2014Safety and efficacy of dacomitinib in korean patients with KRAS wild-type advanced non-small-cell lung cancer refractory to chemotherapy and erlotinib or gefitinib: a phase I/II trial.JOURNAL OF THORACIC ONCOLOGY
2014Tumor MET expression profile predicts the outcome of non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitorsTHORACIC CANCER
2014Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFRONCOLOGIST
2014Immunotherapy in the treatment of non-small cell lung cancerLUNG CANCER
2014Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements PLOS ONE
2014Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers GENOME MEDICINE
2014Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutationsLUNG CANCER
2014A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung CancerJOURNAL OF MOLECULAR DIAGNOSTICS
2014Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinomaLUNG CANCER
2014A prospective phase II trial of s-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY
2014Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinomaLUNG CANCER
2013A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypesANNALS OF ONCOLOGY
2013Glycolysis Inhibition Sensitizes Non–Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK ActivationMOLECULAR CANCER THERAPEUTICS
2013Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung YONSEI MEDICAL JOURNAL
2013Personalized therapy on the horizon for squamous cell carcinoma of the lungLUNG CANCER
2013Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors SUPPORTIVE CARE IN CANCER
2013The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma ANNALS OF ONCOLOGY
2013Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancerLUNG CANCER
2013The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma YONSEI MEDICAL JOURNAL
2013Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinomaFUTURE ONCOLOGY
2013Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung CancerJOURNAL OF CLINICAL ONCOLOGY
2013A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)LUNG CANCER
2013The impact of dermatological toxicities of anti-cancer therapy on the dermatological quality of life of cancer patientsJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
2012A case of synchronous squamous cell carcinoma in the esophagus and stomach GUT AND LIVER
2012Treatment of epidermal growth factor receptor inhibitor-induced acneiform eruption with topical recombinant human epidermal growth factorDERMATOLOGY
2012EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI YONSEI MEDICAL JOURNAL
2012Treatment outcome of patients with anaplastic thyroid cancer: a single center experience YONSEI MEDICAL JOURNAL
2012Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer YONSEI MEDICAL JOURNAL
2012The prognostic factors of resected non-small cell lung cancer with chest wall invasion WORLD JOURNAL OF SURGICAL ONCOLOGY
2012Correlation Between 18F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Mutations in Advanced Lung CancerNUCLEAR MEDICINE AND MOLECULAR IMAGING
2012Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutationMOLECULAR CANCER THERAPEUTICS
2012Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patientsJOURNAL OF THORACIC ONCOLOGY
2012Ei24-deficiency attenuates protein kinase Cα signaling and skin carcinogenesis in mice.INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
2012High EGFR gene copy number and skin rash as predictive markers for EGFR tyrosine kinase inhibitors in patients with advanced squamous cell lung carcinoma. CLINICAL CANCER RESEARCH
2012Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors.CELLULAR IMMUNOLOGY
2012The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma.CANCER CHEMOTHERAPY AND PHARMACOLOGY
2012Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement. CANCER
2012Phase II study of cisplatin with irinotecan as induction chemotherapy followed by chemoradiotherapy for unresectable stage III non-small cell lung cancerANTICANCER RESEARCH
2011Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancerJOURNAL OF THORACIC ONCOLOGY
2011Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. EXPERIMENTAL AND THERAPEUTIC MEDICINE
2011Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: results of a meta-analysis of randomized controlled trialsJOURNAL OF THORACIC ONCOLOGY
2011Multiple target loci assembly sequencing (mTAS).ANALYTICAL BIOCHEMISTRY
2011Lung cancer in never smokers: change of a mindset in the molecular era.LUNG CANCER
2011Thoracoscopic lobectomy is associated with superior compliance with adjuvant chemotherapy in lung cancer.ANNALS OF THORACIC SURGERY
2010Prognostic factors in small cell lung cancer: a new prognostic index in Korean patientsONCOLOGY
2010Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer.JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2010Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trialLUNG CANCER
2010Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells.CANCER LETTERS

Browse

Links